Media Mentions
2019
2019
- What Purdue Pharma’s settlement with Oklahoma means for the opioid crisis By Laura Santhanam (March 2019)
- ‘We owe much to the Sackler family’: How gifts to a top medical school advanced the interests of Purdue Pharma By Andrew Joseph (April 2019)
- The chronic-pain quandary: Amid a reckoning over opioids, a doctor crusades for caution in cutting back By Andrew Joseph (May 2019)
- ‘Game-changer’ - CEO of fentanyl company found guilty of RICO By John Pacenti (May 2019)
- Under Pressure From Opioid Lawsuits, One Pain Research Society Considers Bankruptcy By Francie Diep (May 2019)
- Getting Pharma Out of Medical Education: An Interview with Dr. Adriane Fugh-Berman By Gavin Crowell-Williamson (June 2019)
- US opioid prescribing: the federal government advisers with recent ties to big pharma By Tim Schwab (August 2019)
- ‘Manipulating physicians’: How drug reps pitch your doc By Laura Hensley and Jane Gerster (August 2019)
- Dr. Fugh-Berman spoke about international promotion of opioids at the International Society of Drug Bulletins at Prescrire's offices in Paris. (November 2019)
- Shining a Light on Drug Industry Influence (December 2019)
- Inside the opioid industry’s marketing machine By Sari Horwitz, Scott Higham, Dalton Bennett and Meryl Kornfield (December 2019)
2018
2018
- Report shows ties between opioid makers and patient groups NBC News (February 2018)
- How Much Are Drugmakers To Blame For The Opioid Crisis? (February 2018)
- DOJ Repeats Threat to Hold Opioid Prescribers Accountable - AMA, PharmedOut leaders also pitch solutions at insurers' policy conference By Ryan Basen (March 2018)
- News stories about kratom, an herbal ‘opioid alternative,’ wrongly prioritize propaganda over science By Mary Chris Jaklevic (March 2018)
- How a patient advocacy group is used to promote an Insys drug and other fentanyl meds By Ed Silverman (April 2018)
- Doctors Receive Opioid Training. Big Pharma Funds It. What Could Go Wrong? By Julia Lurie (April 2018)
- Donations of $4,500 overdose antidote were PR gold for drug maker — but some kits were close to expiring By Max Blau (June 2018)
2017
2017
- A Drug Company Hiked Up The Price For Its Overdose Antidote By 600% During An Opioid Epidemic By Azeen Ghorayshi (February 2017)
- Letter sent to Purdue Pharma, Johnson and Johnson, Insys, Mylan, and Depomed By Senator Claire McCaskill (March 2017)
- Trump’s Pick For Drug Czar Hauled In Thousands Of Dollars From Drug Distributors He Wrote Bill To Protect By Josh Keefe (April 2017)
- Lessons From a Professor’s 10-Year Fight to Rein In Pharmaceutical Promotion By Paul Basken (June 2017)
- A Drugmaker Tries To Cash In On The Opioid Epidemic, One State Law At A Time By Jake Harper (June 2017)
- Why Disclosure Policies Don’t Discourage Academe’s Drug Salesmen By Paul Basken (July 2017)
- Amid opioid epidemic, Vivitrol finds success marketing to judges and jailers By Michael Walsh (July 2017)
- To Grow Market Share, A Drugmaker Pitches Its Product To Judges By Jake Harper (August 2017)
- Cherry Hill mom: Daughter's opioid death was caused by 'corporate greed' By Don Sapatkin (September 2017)
- Christie: Pharma industry to work with NIH on opioid crisis By Jonathan Lai and Don Sapatkin (September 2017)
- As he chairs Trump's opioid commission, Christie champions his home-state drug companies By Gregory Korte (October 2017)
- Senator Harris Launches Investigation into Pharmaceutical Manufacturer Alkermes Regarding Opioid Addiction Treatment Manipulation By Office of Sen. Kamala D. Harris (November 2017)
- Pain Management and the Opioid Crisis By PhRMA and Purdue Pharma (November 2017)
- The Insanity of Taxpayer-Funded Addiction By The New York Times Editorial Board (November 2017)
2016
2016
- Drug salesmen arrested for paying doctors to prescribe fentanyl By Liz Szabo (June 2016)
- Pfizer agrees to opioid marketing deal to escape a lawsuit by Chicago By Ed Silverman (July 2016)
- Pfizer agrees to truth in opioid marketing By Lenny Bernstein (July 2016)
- Pfizer highlights risks of opioid painkillers By Kate Gibson (July 2016)
- A potent painkiller, and the drug maker’s marketing, are faulted in a woman’s death By David Armstrong (September 2016)
- Public health school launches open online courses on opioids By Connor O'Kelley (October 2016)
- The drug industry’s answer to opioid addiction: More pills By Ariana Eunjung Cha (October 2016)